Dr. Mubarak Almansour

Section Head, Adult Medical Oncology Section
Consultant, Adult Medical Oncology
Oncology Department, Princess Noorah Oncology Center
King Abdulaziz Medical City, Ministry of National Guard Health Affairs - Jeddah

10 : 15 – 10 : 25

24 June | 2023 Day 2

Adjuvant nivolumab plus ipilimumab vs placebo for patients with localized renal cell carcinoma at high risk of relapse after nephrectomy: Subgroup analyses from the phase 3 CheckMate 914 (part A) trial.